Walleye Capital’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$159K Buy
13,300
+8,700
+189% +$125K ﹤0.01% 3459
2025
Q4
$71.1K Sell
4,600
-20,000
-81% -$368K ﹤0.01% 3987
2025
Q3
$532K Buy
+24,600
New +$549K ﹤0.01% 2556
2025
Q1
Sell
-18,600
Closed -$394K 5042
2024
Q4
$394K Hold
18,600
﹤0.01% 3190
2024
Q3
$600K Sell
18,600
-3,200
-15% -$94.5K ﹤0.01% 3125
2024
Q2
$519K Buy
21,800
+18,900
+652% +$485K ﹤0.01% 3484
2024
Q1
$86.5K Buy
+2,900
New +$90.7K ﹤0.01% 4463

Other funds holding SGRY

Walleye Capital's SGRY Position: Q1 2026 in Review

Walleye Capital reduced its Surgery Partners (SGRY) stake by 99% in Q1 2026, selling an estimated $5.29M and leaving 3,162 shares worth $37.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3962.

Walleye Capital first reported a position in SGRY in Q3 2021 and has held it in 12 quarters since. The position peaked at $16.1M in Q3 2024. 182 funds tracked by Wall St. Rank hold SGRY as of Q1 2026.

  • Walleye Capital held 3,162 shares of Surgery Partners worth $37.7K as of Q1 2026.
  • Walleye Capital sold 368,833 Surgery Partners shares in Q1 2026, an estimated $5.29M.
  • Surgery Partners made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #3962 holding.
  • Walleye Capital first reported a position in Surgery Partners in Q3 2021 and has held it in 12 quarters since.
  • Walleye Capital's Surgery Partners position peaked at $16.1M in Q3 2024.
  • 182 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.